切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (02) : 114 -118. doi: 10.3877/cma.j.issn.2095-3259.2014.02.009

所属专题: 文献

专家论坛

产褥期静脉血栓栓塞性疾病的诊断与处理
刘芮汐1, 漆洪波1,()   
  1. 1. 400016 重庆医科大学附属第一医院妇产科
  • 收稿日期:2014-03-09 出版日期:2014-05-18
  • 通信作者: 漆洪波

Clinical diagnosis and treatment of venous thromboembolism during the postpartum period

Ruixi Liu1, Hongbo Qi1()   

  • Received:2014-03-09 Published:2014-05-18
  • Corresponding author: Hongbo Qi
引用本文:

刘芮汐, 漆洪波. 产褥期静脉血栓栓塞性疾病的诊断与处理[J/OL]. 中华产科急救电子杂志, 2014, 03(02): 114-118.

Ruixi Liu, Hongbo Qi. Clinical diagnosis and treatment of venous thromboembolism during the postpartum period[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(02): 114-118.

静脉血栓栓塞性疾病是产褥期妇女严重并发症之一。静脉血栓栓塞性疾病包括深静脉血栓形成及肺栓塞两种。由于该病有潜在致死性,因此早期诊断和规范治疗是改善孕产妇妊娠结局的关键。现就产褥期静脉血栓栓塞性疾病的形成机制、诊断及治疗作一阐述。

Venous thromboembolism is one of the severe complications during the postpartum period. Venous thromboembolism includes both deep venous thrombosis and pulmonary embolism. As the disease can become life-threatening, so early diagnosis and standard treatment are the keys to improve pregnancy outcomes. This paper describes the mechanism, diagnosis and treatment of puerperal venous thromboembolism.

[1]
Richter ON, Rath W. Thromboembolic diseases in pregnancy[J]. Z Geburtshilfe Neonatal, 2007, 211(1):1-7.
[2]
James AH. Prevention and management of venous thromboembolism in pregnancy[J]. Am J Med, 2007,120 (10 Suppl 2):S26-S34.
[3]
Kyrle PA, Eichinger S. Deep vein thrombosis[J]. Lancet, 2005, 365(9465):1163-1174.
[4]
James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period:incidence, risk factors, and mortality[J].Am J Obstet Gynecol, 2006, 194(5):1311-1315.
[5]
Voral S, Ghosh K, Shetty S, et al. Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western india[J].Thromb J, 2007, 5(1):9.
[6]
马水清,白春梅,盖铭英. 妊娠期及产褥期静脉血栓12例临床分析[J]. 中华妇产科杂志,1999, 34(11):649-651.
[7]
Alisa SW, Nigel M. Venous thromboembolism risk factors, biomarkers, and treatment [J]. Arterioscler Thromb Vasc Biol, 2009, 29(3):326-331.
[8]
James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period[J]. Am Obstet Gynecol, 2005, 193(1):216-219.
[9]
Szecsi PB, Jørgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy[J]. Thromb Haemost, 2010, 103(4):718-727.
[10]
韩凤英,陈晓霞,谢倩,等. 妊娠及产褥期下肢深静脉血栓形成溶栓治疗[J]. 中国现代医学杂志,2006, 16(9):1425-1429.
[11]
Weg JG. Venous thromboembolism in pregnancy[J]. Semin Reprod Crit Care Med, 1998, 19:231-241.
[12]
Zakzouk MS. The congenital warfarin syndrome[J]. J Laryngol Otol, 1986, 100(2):215-219.
[13]
Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy[J]. Am J Med Genet, 1993, 45:17-21.
[14]
Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J]. Chest, 2004, 126(3 Suppl):188S-203S.
[15]
Spyropoulos AC, Merli G. Management of venous thromboembolism in the elderly[J]. Drugs Aging, 2006, 23(8):651-671.
[16]
Frame JN. The heparin-induced thrombocytopenia task force model: implementing quality improvement and economic outcome initiatives[J]. Seminars in Hematology, 2005, 42 (3 Suppl):28-35.
[17]
Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy[J]. Chest, 2004, 126(3 Suppl):627S-644S.
[18]
Wan S, Quinlan DJ, Agenelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials[J]. Circulation, 2004, 110:744-749.
[19]
Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy:a systematic review of safety and efficacy[J]. Blood, 2005, 106(2):401-407.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[3] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[7] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[8] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[9] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[10] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[11] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[12] 帖璇, 苏晓乐, 王利华. 抗中性粒细胞胞质抗体相关性血管炎治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 345-351.
[13] 于洁, 金小红, 顾艳楣, 王慧, 葛杨杨, 李燕. 癌症相关静脉血栓栓塞症患者疾病体验与需求的质性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 739-744.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?